share_log

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director KANTOFF AARON

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities

Avalo Therapeutics | 3:首次持股声明
SEC announcement ·  04/03 16:04
Moomoo AI 已提取核心信息
Aaron Kantoff, a director and 10% owner of Avalo Therapeutics, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated March 28, 2024. The form, which was signed on April 3, 2024, indicates that Kantoff does not beneficially own any non-derivative or derivative securities of the company. The filing is a routine disclosure required by the Securities Exchange Act of 1934 and the Investment Company Act of 1940, which mandates insiders to report their securities holdings in the company. The address listed for Kantoff is c/o Avalo Therapeutics, Inc. at 540 Gaither Road, Suite 400, Rockville, MD, 20850.
Aaron Kantoff, a director and 10% owner of Avalo Therapeutics, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated March 28, 2024. The form, which was signed on April 3, 2024, indicates that Kantoff does not beneficially own any non-derivative or derivative securities of the company. The filing is a routine disclosure required by the Securities Exchange Act of 1934 and the Investment Company Act of 1940, which mandates insiders to report their securities holdings in the company. The address listed for Kantoff is c/o Avalo Therapeutics, Inc. at 540 Gaither Road, Suite 400, Rockville, MD, 20850.
根据2024年3月28日提交的表格3,Avalo Therapeutics, Inc. 的董事兼10%所有者亚伦·坎托夫已向美国证券交易委员会提交了初步的证券实益拥有权声明。该表格于2024年4月3日签署,表明坎托夫不以实益方式拥有该公司的任何非衍生或衍生证券。该文件是1934年《证券交易法》和1940年《投资公司法》要求的例行披露,后者要求内部人士报告其持有的公司证券。坎托夫列出的地址是位于马里兰州罗克维尔盖瑟路540号400号20850号Avalo Therapeutics, Inc.的 c/o Avalo Therapeutics, Inc.
根据2024年3月28日提交的表格3,Avalo Therapeutics, Inc. 的董事兼10%所有者亚伦·坎托夫已向美国证券交易委员会提交了初步的证券实益拥有权声明。该表格于2024年4月3日签署,表明坎托夫不以实益方式拥有该公司的任何非衍生或衍生证券。该文件是1934年《证券交易法》和1940年《投资公司法》要求的例行披露,后者要求内部人士报告其持有的公司证券。坎托夫列出的地址是位于马里兰州罗克维尔盖瑟路540号400号20850号Avalo Therapeutics, Inc.的 c/o Avalo Therapeutics, Inc.
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息